Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
Zhao JJ, Kumarakulasinghe NB, Muthu V, Lee M, Walsh R, Low JL, Choo J, Tan HL, Chong WQ, Ang Y, Chan G, Yong WP, Huang Y, Ngoi N, Wong A.
Zhao JJ, et al. Among authors: low jl.
Oncology. 2021;99(3):192-202. doi: 10.1159/000512000. Epub 2021 Jan 13.
Oncology. 2021.
PMID: 33440374